Macrolide [EPC]

Macrolide [EPC] was reported 18584 times

Drugs of the Macrolide [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI FACTOR V ANTIBODY 19 0.6786
1 GRIP STRENGTH 123 0.5371
2 UMBILICAL ERYTHEMA 17 0.2787
3 SWOLLEN JOINT COUNT 57 0.2280
4 LUPUS VULGARIS 170 0.1349
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 75 0.1123
6 PORPHYRIA ACUTE 137 0.0955
7 DISLOCATION OF VERTEBRA 210 0.0920
8 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 190 0.0916
9 BLOODY DISCHARGE 101 0.0884
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 174 0.0869
11 X-RAY ABNORMAL 150 0.0838
12 SERONEGATIVE ARTHRITIS 94 0.0820
13 RETINITIS 133 0.0769
14 DEAFNESS PERMANENT 15 0.0765
15 INTERNATIONAL NORMALISED RATIO FLUCTUATION 148 0.0715
16 SWOLLEN JOINT COUNT INCREASED 170 0.0533
17 HYPHAEMA 26 0.0498
18 DRUG TOLERANCE DECREASED 140 0.0498
19 RHEUMATIC FEVER 221 0.0495
20 FACET JOINT SYNDROME 159 0.0488
21 BONE EROSION 160 0.0452
22 MONOCYTOSIS 27 0.0435
23 NECROSIS ISCHAEMIC 20 0.0434
24 RHEUMATOID FACTOR POSITIVE 225 0.0389
25 PNEUMOCOCCAL INFECTION 23 0.0389
26 BREAST CANCER STAGE III 247 0.0381
27 PERIORBITAL PAIN 32 0.0378
28 PERIPHERAL VENOUS DISEASE 152 0.0372
29 FAECAL VOLUME DECREASED 17 0.0354
30 DUODENAL ULCER PERFORATION 258 0.0347
31 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 18 0.0321
32 C-REACTIVE PROTEIN ABNORMAL 205 0.0319
33 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 224 0.0312
34 LYME DISEASE 99 0.0297
35 ALLERGIC OEDEMA 19 0.0293
36 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 31 0.0292
37 C-REACTIVE PROTEIN 27 0.0291
38 MEASLES 15 0.0278
39 MATERNAL EXPOSURE TIMING UNSPECIFIED 103 0.0274
40 SEPSIS NEONATAL 21 0.0259
41 HELICOBACTER INFECTION 247 0.0240
42 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 153 0.0235
43 EYELID PAIN 46 0.0226
44 INTRA-UTERINE DEATH 36 0.0224
45 CORNEAL PERFORATION 14 0.0222
46 HYPERPARATHYROIDISM SECONDARY 55 0.0219
47 PNEUMONIA STREPTOCOCCAL 24 0.0219
48 ENDOCRINE OPHTHALMOPATHY 19 0.0219
49 AUTOIMMUNE DISORDER 212 0.0217
50 NEPHROGENIC ANAEMIA 99 0.0214
51 WOUND INFECTION 234 0.0213
52 GRIP STRENGTH DECREASED 187 0.0212
53 REBOUND ACID HYPERSECRETION 64 0.0211
54 FOLLICULITIS 220 0.0210
55 MUSCLE INJURY 173 0.0209
56 PYLORIC STENOSIS 17 0.0201
57 BURSITIS 235 0.0193
58 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 24 0.0190
59 ULCERATIVE KERATITIS 52 0.0190
60 EXOSTOSIS 168 0.0184
61 LIP DRY 166 0.0183
62 PEMPHIGUS 227 0.0181
63 DEATH NEONATAL 25 0.0180
64 PANCREATIC MASS 19 0.0178
65 HYPERCHOLESTEROLAEMIA 169 0.0175
66 SPONDYLITIS 63 0.0173
67 FOOT DEFORMITY 190 0.0171
68 EXPOSURE TO SARS-COV-2 29 0.0170
69 WALKING AID USER 111 0.0168
70 CORNEAL ABRASION 23 0.0168
71 FORCED EXPIRATORY VOLUME DECREASED 47 0.0166
72 HAND DEFORMITY 217 0.0165
73 JOINT RANGE OF MOTION DECREASED 221 0.0165
74 OTOTOXICITY 29 0.0157
75 BRONCHIAL OBSTRUCTION 22 0.0157
76 LIVE BIRTH 129 0.0154
77 VERTIGO POSITIONAL 26 0.0148
78 CROSS SENSITIVITY REACTION 14 0.0144
79 PERICARDITIS 237 0.0141
80 STENOTROPHOMONAS INFECTION 18 0.0133
81 RED BLOOD CELL SEDIMENTATION RATE INCREASED 146 0.0132
82 IRON DEFICIENCY 58 0.0129
83 OLIGOHYDRAMNIOS 43 0.0129
84 LUPUS-LIKE SYNDROME 116 0.0128
85 OBSTRUCTION GASTRIC 15 0.0117
86 IRRITABLE BOWEL SYNDROME 240 0.0112
87 SYNOVITIS 200 0.0111
88 DEAFNESS NEUROSENSORY 36 0.0109
89 GLOSSODYNIA 243 0.0108
90 SCIATICA 173 0.0108
91 FOREIGN BODY SENSATION IN EYES 69 0.0108
92 FIBROMYALGIA 253 0.0104
93 COAGULATION TIME PROLONGED 16 0.0103
94 SPINAL FUSION SURGERY 41 0.0101
95 OBESITY 160 0.0100
96 PULMONARY FIBROSIS 192 0.0100
97 DEAFNESS BILATERAL 17 0.0100
98 PREMATURE RUPTURE OF MEMBRANES 24 0.0099
99 EYE PAIN 543 0.0096
100 WOUND 264 0.0094
101 END STAGE RENAL DISEASE 172 0.0094
102 LOWER RESPIRATORY TRACT CONGESTION 16 0.0094
103 ABDOMINAL MASS 25 0.0093
104 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 158 0.0093
105 RESPIRATORY ACIDOSIS 36 0.0091
106 DIPLEGIA 18 0.0091
107 HEPATIC CIRRHOSIS 170 0.0090
108 TOXIC EPIDERMAL NECROLYSIS 137 0.0090
109 HAEMORRHAGIC DIATHESIS 32 0.0090
110 JOINT DISLOCATION 94 0.0089
111 LIVER INJURY 218 0.0089
112 TYPE 2 DIABETES MELLITUS 297 0.0088
113 PRESCRIBED OVERDOSE 165 0.0085
114 MUSCLE CONTRACTURE 17 0.0084
115 CHRONIC KIDNEY DISEASE 628 0.0083
116 TORSADE DE POINTES 63 0.0080
117 BLEPHARITIS 32 0.0080
118 MIXED LIVER INJURY 24 0.0080
119 EYELID IRRITATION 20 0.0080
120 SYSTEMIC LUPUS ERYTHEMATOSUS 281 0.0079
121 HORDEOLUM 34 0.0079
122 EAR INFECTION 208 0.0078
123 BRONCHITIS CHRONIC 19 0.0078
124 ARTHRITIS INFECTIVE 36 0.0078
125 LOWER LIMB FRACTURE 149 0.0077
126 PHOTOPHOBIA 145 0.0077
127 HIP ARTHROPLASTY 118 0.0077
128 OCULAR DISCOMFORT 86 0.0077
129 PSEUDOMEMBRANOUS COLITIS 17 0.0076
130 EYE INJURY 23 0.0076
131 STUPOR 24 0.0075
132 EYE INFECTION 83 0.0073
133 EYELID MARGIN CRUSTING 21 0.0073
134 THROMBOPHLEBITIS SUPERFICIAL 22 0.0073
135 CHEST INJURY 15 0.0072
136 PNEUMONIA FUNGAL 28 0.0071
137 WEIGHT FLUCTUATION 74 0.0071
138 IMPAIRED HEALING 231 0.0070
139 SWELLING OF EYELID 44 0.0070
140 RESPIRATORY RATE DECREASED 22 0.0070
141 DELIRIUM 243 0.0070
142 OCULOGYRIC CRISIS 15 0.0070
143 SKIN WRINKLING 19 0.0070
144 LOW BIRTH WEIGHT BABY 55 0.0069
145 WHEEZING 402 0.0068
146 PUSTULAR PSORIASIS 23 0.0067
147 ECONOMIC PROBLEM 101 0.0067
148 HYPERCAPNIA 20 0.0066
149 BLOOD CHLORIDE DECREASED 17 0.0066
150 PREGNANCY 130 0.0065
151 ACCIDENTAL EXPOSURE 27 0.0065
152 MUCOUS STOOLS 32 0.0065
153 IMPAIRED GASTRIC EMPTYING 88 0.0064
154 CONJUNCTIVAL HYPERAEMIA 23 0.0064
155 MOUTH SWELLING 37 0.0064
156 EYE INFLAMMATION 61 0.0064
157 CLOSTRIDIUM TEST POSITIVE 14 0.0063
158 DYSPHORIA 32 0.0063
159 FREQUENT BOWEL MOVEMENTS 170 0.0063
160 ABDOMINAL RIGIDITY 17 0.0063
161 POTENTIATING DRUG INTERACTION 21 0.0063
162 MATERNAL EXPOSURE DURING PREGNANCY 557 0.0062
163 LOWER RESPIRATORY TRACT INFECTION 283 0.0062
164 CAESAREAN SECTION 72 0.0062
165 OSTEOARTHRITIS 259 0.0061
166 CONGENITAL ANOMALY 47 0.0061
167 EYE DISCHARGE 63 0.0061
168 PATHOGEN RESISTANCE 55 0.0060
169 NIGHT SWEATS 192 0.0060
170 VASCULAR DEVICE INFECTION 27 0.0059
171 JAUNDICE CHOLESTATIC 21 0.0059
172 PLATELET COUNT INCREASED 77 0.0059
173 CONTRAINDICATED PRODUCT ADMINISTERED 178 0.0059
174 BLOOD CHOLESTEROL INCREASED 274 0.0059
175 GESTATIONAL DIABETES 28 0.0059
176 RESPIRATORY DISORDER 174 0.0058
177 INFUSION SITE REACTION 17 0.0057
178 PLANTAR FASCIITIS 19 0.0057
179 DIVERTICULUM 40 0.0056
180 KERATITIS 17 0.0056
181 BLISTER 314 0.0056
182 BLEPHAROSPASM 35 0.0056
183 EAR PAIN 108 0.0055
184 OEDEMA 299 0.0055
185 SKIN WARM 32 0.0055
186 SPUTUM DISCOLOURED 52 0.0055
187 EYE IRRITATION 314 0.0054
188 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 18 0.0054
189 INFLAMMATORY BOWEL DISEASE 52 0.0053
190 APPETITE DISORDER 35 0.0053
191 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 41 0.0053
192 SECRETION DISCHARGE 66 0.0053
193 CEREBRAL ATROPHY 21 0.0053
194 ROAD TRAFFIC ACCIDENT 219 0.0052
195 ABORTION SPONTANEOUS 209 0.0052
196 KNEE ARTHROPLASTY 109 0.0052
197 ERYTHEMA OF EYELID 28 0.0052
198 CEREBRAL HAEMATOMA 17 0.0051
199 ARTHROPATHY 281 0.0051
200 PSORIATIC ARTHROPATHY 205 0.0050
201 DRUG INTOLERANCE 485 0.0050
202 DISCOMFORT 303 0.0050
203 RESPIRATORY RATE INCREASED 44 0.0050
204 STEVENS-JOHNSON SYNDROME 110 0.0049
205 UMBILICAL HERNIA 23 0.0049
206 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
207 LABORATORY TEST ABNORMAL 145 0.0049
208 HYPOMANIA 18 0.0049
209 TEARFULNESS 21 0.0049
210 EAR PRURITUS 17 0.0048
211 WHITE BLOOD CELL COUNT INCREASED 186 0.0048
212 PRESCRIBED UNDERDOSE 96 0.0048
213 TENDERNESS 50 0.0048
214 TRICUSPID VALVE INCOMPETENCE 38 0.0048
215 PERIORBITAL SWELLING 27 0.0048
216 RECTAL HAEMORRHAGE 205 0.0048
217 ANAPHYLACTIC REACTION 263 0.0048
218 PREMATURE BABY 143 0.0047
219 COLITIS ULCERATIVE 210 0.0047
220 MATERNAL DRUGS AFFECTING FOETUS 36 0.0047
221 SUDDEN CARDIAC DEATH 16 0.0047
222 OSTEOPOROSIS 193 0.0047
223 TUBULOINTERSTITIAL NEPHRITIS 86 0.0046
224 INJURY 321 0.0046
225 ATELECTASIS 44 0.0045
226 OCULAR HYPERAEMIA 216 0.0045
227 TYPE I HYPERSENSITIVITY 16 0.0045
228 NEONATAL RESPIRATORY DISTRESS SYNDROME 16 0.0045
229 HEPATIC NECROSIS 17 0.0045
230 THERAPEUTIC AGENT TOXICITY 15 0.0045
231 RHINITIS ALLERGIC 20 0.0045
232 HIATUS HERNIA 58 0.0045
233 CONJUNCTIVITIS 83 0.0045
234 ULCER HAEMORRHAGE 30 0.0044
235 ABNORMAL SENSATION IN EYE 19 0.0044
236 MOBILITY DECREASED 316 0.0044
237 LUNG DISORDER 215 0.0044
238 EXPOSURE DURING PREGNANCY 272 0.0044
239 STILLBIRTH 21 0.0043
240 EYE SWELLING 160 0.0043
241 THERAPEUTIC PRODUCT EFFECT DECREASED 192 0.0043
242 PATENT DUCTUS ARTERIOSUS 17 0.0043
243 DRUG-INDUCED LIVER INJURY 134 0.0043
244 FACIAL PAIN 38 0.0043
245 SKIN NECROSIS 22 0.0042
246 INCREASED TENDENCY TO BRUISE 39 0.0042
247 PURULENT DISCHARGE 18 0.0042
248 PIGMENTATION DISORDER 26 0.0042
249 HYPOTONIA 42 0.0042
250 SCOLIOSIS 26 0.0042
251 JOINT STIFFNESS 110 0.0042
252 CHOLECYSTITIS CHRONIC 28 0.0042
253 MYOSITIS 37 0.0041
254 EYE OPERATION 19 0.0041
255 GASTROINTESTINAL MOTILITY DISORDER 22 0.0041
256 ASTHMA 460 0.0041
257 AMNESIA 264 0.0041
258 DERMATITIS ALLERGIC 51 0.0041
259 LACRIMATION INCREASED 122 0.0040
260 DERMATITIS CONTACT 46 0.0040
261 INFUSION RELATED REACTION 266 0.0040
262 LIVER DISORDER 177 0.0040
263 NASAL DRYNESS 25 0.0040
264 MUSCULOSKELETAL PAIN 208 0.0040
265 BREAST CANCER STAGE II 33 0.0040
266 PHARYNGEAL OEDEMA 61 0.0040
267 PARANASAL SINUS DISCOMFORT 15 0.0040
268 C-REACTIVE PROTEIN INCREASED 143 0.0039
269 BLOOD PRESSURE DIASTOLIC INCREASED 18 0.0039
270 SYNOVIAL CYST 18 0.0039
271 PHARYNGEAL SWELLING 38 0.0039
272 PANCREATITIS 205 0.0039
273 DRUG INTERACTION 615 0.0039
274 PRODUCT USE COMPLAINT 61 0.0039
275 CONTUSION 372 0.0039
276 ILL-DEFINED DISORDER 234 0.0038
277 INFECTION 555 0.0038
278 SWELLING 358 0.0038
279 LIVER FUNCTION TEST INCREASED 82 0.0038
280 ONYCHOMADESIS 16 0.0038
281 PRODUCT PHYSICAL CONSISTENCY ISSUE 21 0.0038
282 DISABILITY 75 0.0038
283 PRE-ECLAMPSIA 18 0.0038
284 RENAL TUBULAR NECROSIS 37 0.0038
285 AZOTAEMIA 15 0.0038
286 CANDIDIASIS 15 0.0037
287 HYPERTRANSAMINASAEMIA 26 0.0037
288 HYPERSENSITIVITY 689 0.0037
289 HEPATIC ENZYME INCREASED 253 0.0037
290 GASTROINTESTINAL DISORDER 331 0.0037
291 DRUG EXPOSURE DURING PREGNANCY 125 0.0037
292 DIVERTICULUM INTESTINAL 16 0.0037
293 ONYCHOMYCOSIS 16 0.0036
294 SPINAL OSTEOARTHRITIS 32 0.0036
295 PHYSICAL DISABILITY 16 0.0036
296 ORAL PAIN 81 0.0036
297 STOMATITIS 219 0.0036
298 SEASONAL ALLERGY 51 0.0036
299 RENAL FAILURE 477 0.0036
300 MYOPATHY 31 0.0036
301 RHABDOMYOLYSIS 149 0.0036
302 MITRAL VALVE INCOMPETENCE 40 0.0035
303 RENAL CYST 28 0.0035
304 AORTIC VALVE INCOMPETENCE 15 0.0035
305 SINUSITIS 361 0.0035
306 SARS-COV-2 TEST POSITIVE 46 0.0035
307 ELECTROCARDIOGRAM QT PROLONGED 124 0.0034
308 SLEEP DISORDER 243 0.0034
309 RENAL INJURY 102 0.0034
310 RASH PUSTULAR 25 0.0034
311 MUSCULOSKELETAL CHEST PAIN 53 0.0034
312 SENSITIVITY TO WEATHER CHANGE 18 0.0034
313 ERYSIPELAS 17 0.0034
314 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 240 0.0034
315 NODULE 44 0.0034
316 STAPHYLOCOCCAL INFECTION 111 0.0034
317 INTRAOCULAR PRESSURE INCREASED 43 0.0034
318 OSTEOPENIA 51 0.0034
319 ABDOMINAL DISCOMFORT 562 0.0033
320 DYSLIPIDAEMIA 17 0.0033
321 RHEUMATOID ARTHRITIS 379 0.0033
322 MULTIPLE INJURIES 21 0.0033
323 MUSCULOSKELETAL STIFFNESS 292 0.0033
324 URTICARIA 555 0.0033
325 RASH VESICULAR 16 0.0033
326 ACUTE KIDNEY INJURY 506 0.0033
327 POOR VENOUS ACCESS 34 0.0033
328 INFLAMMATION 169 0.0033
329 PSEUDOMONAS INFECTION 28 0.0033
330 GASTROOESOPHAGEAL REFLUX DISEASE 261 0.0032
331 DIABETIC NEUROPATHY 16 0.0032
332 HAEMODIALYSIS 27 0.0032
333 SWOLLEN TONGUE 100 0.0032
334 NAIL DISORDER 28 0.0032
335 ASPERGILLUS INFECTION 21 0.0032
336 ELECTROCARDIOGRAM ABNORMAL 25 0.0032
337 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 153 0.0032
338 HYPERLIPIDAEMIA 38 0.0032
339 DRY MOUTH 258 0.0032
340 PREMATURE DELIVERY 50 0.0031
341 SKIN ATROPHY 18 0.0031
342 CARDIAC MURMUR 27 0.0031
343 FEELING HOT 191 0.0031
344 ASTHENOPIA 17 0.0031
345 FOETAL DEATH 16 0.0031
346 GASTRITIS 81 0.0031
347 ARTHRITIS 241 0.0031
348 OBSTRUCTIVE AIRWAYS DISORDER 34 0.0031
349 HEPATOMEGALY 30 0.0030
350 THERAPY NON-RESPONDER 137 0.0030
351 GENERAL PHYSICAL HEALTH DETERIORATION 350 0.0030
352 CHOLESTASIS 58 0.0030
353 INFUSION SITE SWELLING 19 0.0030
354 CLOSTRIDIUM DIFFICILE COLITIS 32 0.0030
355 CARDIAC VALVE DISEASE 17 0.0030
356 VENTRICULAR SEPTAL DEFECT 17 0.0030
357 DRUG LEVEL INCREASED 49 0.0030
358 PRODUCT PACKAGING ISSUE 28 0.0029
359 BRONCHITIS 218 0.0029
360 PULMONARY HAEMORRHAGE 23 0.0029
361 AMMONIA INCREASED 15 0.0029
362 DRUG TOXICITY 40 0.0029
363 PRODUCTIVE COUGH 140 0.0029
364 PHLEBITIS 15 0.0029
365 DERMATITIS BULLOUS 21 0.0029
366 INTRACRANIAL PRESSURE INCREASED 16 0.0029
367 HEART RATE ABNORMAL 16 0.0029
368 SINUS HEADACHE 17 0.0029
369 RENAL FAILURE CHRONIC 22 0.0029
370 ABDOMINAL PAIN UPPER 587 0.0028
371 FRUSTRATION TOLERANCE DECREASED 23 0.0028
372 ARTHROPOD BITE 21 0.0028
373 PNEUMONIA BACTERIAL 26 0.0028
374 VISUAL IMPAIRMENT 351 0.0028
375 PREMATURE LABOUR 16 0.0028
376 SHOCK HAEMORRHAGIC 23 0.0028
377 ANHEDONIA 74 0.0028
378 DYSPEPSIA 276 0.0028
379 VENTRICULAR FIBRILLATION 31 0.0028
380 HYPOAESTHESIA 416 0.0028
381 NORMAL NEWBORN 15 0.0028
382 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 15 0.0028
383 RALES 16 0.0028
384 MOTOR DYSFUNCTION 28 0.0027
385 RENAL PAIN 29 0.0027
386 OEDEMA PERIPHERAL 332 0.0027
387 CHOKING SENSATION 15 0.0027
388 IMPAIRED QUALITY OF LIFE 39 0.0027
389 BODY TEMPERATURE INCREASED 55 0.0027
390 BRAIN OEDEMA 34 0.0027
391 DRY EYE 134 0.0027
392 PRODUCT ADMINISTRATION INTERRUPTED 21 0.0027
393 SLEEP APNOEA SYNDROME 51 0.0027
394 BACK INJURY 29 0.0027
395 MUSCULAR WEAKNESS 303 0.0027
396 TREATMENT FAILURE 220 0.0027
397 COAGULOPATHY 44 0.0026
398 NEUTROPHILIA 15 0.0026
399 ATRIAL FLUTTER 21 0.0026
400 URINE OUTPUT DECREASED 23 0.0026
401 CROHN'S DISEASE 18 0.0026
402 RIB FRACTURE 54 0.0026
403 EYE PRURITUS 88 0.0026
404 MIGRAINE 250 0.0026
405 JOINT SWELLING 315 0.0026
406 DRUG RESISTANCE 67 0.0026
407 VENTRICULAR EXTRASYSTOLES 27 0.0026
408 ENTEROCOLITIS 15 0.0026
409 HYPOGAMMAGLOBULINAEMIA 17 0.0026
410 PRODUCT ADMINISTRATION ERROR 52 0.0026
411 TASTE DISORDER 52 0.0026
412 BLOOD SODIUM DECREASED 48 0.0025
413 CANDIDA INFECTION 43 0.0025
414 SINUS TACHYCARDIA 36 0.0025
415 UPPER RESPIRATORY TRACT INFECTION 117 0.0025
416 DYSTONIA 49 0.0025
417 PLEURISY 15 0.0025
418 LIP SWELLING 84 0.0025
419 THINKING ABNORMAL 47 0.0025
420 DYSPNOEA EXERTIONAL 95 0.0025
421 RASH MACULO-PAPULAR 56 0.0025
422 BLOOD PRESSURE SYSTOLIC INCREASED 49 0.0025
423 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 43 0.0025
424 ELECTROLYTE IMBALANCE 29 0.0025
425 RESPIRATORY TRACT INFECTION 65 0.0025
426 PHARYNGITIS STREPTOCOCCAL 27 0.0025
427 SENSATION OF FOREIGN BODY 21 0.0025
428 INTERNATIONAL NORMALISED RATIO INCREASED 71 0.0025
429 PURPURA 22 0.0025
430 FOETAL GROWTH RESTRICTION 15 0.0025
431 UPPER-AIRWAY COUGH SYNDROME 20 0.0024
432 AKATHISIA 33 0.0024
433 GALLBLADDER DISORDER 43 0.0024
434 CHEST PAIN 446 0.0024
435 GASTROENTERITIS 35 0.0024
436 NECK PAIN 134 0.0024
437 ABDOMINAL PAIN 557 0.0024
438 FOETAL EXPOSURE DURING PREGNANCY 194 0.0024
439 IRON DEFICIENCY ANAEMIA 22 0.0024
440 LUNG INFILTRATION 21 0.0024
441 VOMITING 1117 0.0024
442 SWELLING FACE 154 0.0024
443 VITAMIN D DEFICIENCY 23 0.0024
444 RASH 1025 0.0023
445 GENERALISED OEDEMA 29 0.0023
446 PHARYNGITIS 29 0.0023
447 EYE MOVEMENT DISORDER 16 0.0023
448 HYPERTENSION 492 0.0023
449 SNEEZING 52 0.0023
450 CHOLELITHIASIS 76 0.0023
451 CONFUSIONAL STATE 374 0.0023
452 MULTI-ORGAN FAILURE 40 0.0023
453 INTERSTITIAL LUNG DISEASE 112 0.0023
454 MEMORY IMPAIRMENT 316 0.0023
455 MOUTH ULCERATION 48 0.0023
456 CARDIOMEGALY 28 0.0023
457 PULMONARY CONGESTION 30 0.0023
458 ATRIAL SEPTAL DEFECT 19 0.0023
459 ACUTE HEPATIC FAILURE 31 0.0023
460 DENTAL CARIES 25 0.0023
461 THROMBOTIC MICROANGIOPATHY 22 0.0023
462 NEPHROPATHY 21 0.0022
463 NEUTROPHIL COUNT INCREASED 23 0.0022
464 GAIT INABILITY 75 0.0022
465 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
466 POST-TRAUMATIC STRESS DISORDER 15 0.0022
467 HAEMODYNAMIC INSTABILITY 17 0.0022
468 EPILEPSY 68 0.0022
469 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 116 0.0022
470 HEPATIC FAILURE 67 0.0022
471 EYE DISORDER 73 0.0022
472 PERIPHERAL SWELLING 342 0.0022
473 MASS 31 0.0022
474 STATUS EPILEPTICUS 25 0.0022
475 COLD SWEAT 39 0.0022
476 UPPER LIMB FRACTURE 44 0.0022
477 FOOD ALLERGY 17 0.0022
478 OESOPHAGITIS 24 0.0022
479 VIRAL INFECTION 73 0.0022
480 RENAL FAILURE ACUTE 93 0.0022
481 BLOOD CREATINE PHOSPHOKINASE INCREASED 63 0.0022
482 POOR QUALITY SLEEP 47 0.0022
483 INFUSION SITE PAIN 28 0.0022
484 CELLULITIS 109 0.0022
485 CLOSTRIDIUM DIFFICILE INFECTION 47 0.0022
486 ANXIETY 609 0.0021
487 VITREOUS FLOATERS 21 0.0021
488 OXYGEN SATURATION DECREASED 120 0.0021
489 ORAL CANDIDIASIS 28 0.0021
490 BIPOLAR DISORDER 23 0.0021
491 DEPRESSION 481 0.0021
492 LEUKOCYTOSIS 38 0.0021
493 NASOPHARYNGITIS 387 0.0021
494 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
495 BLINDNESS 85 0.0021
496 BLOOD MAGNESIUM DECREASED 18 0.0021
497 VISION BLURRED 285 0.0021
498 PNEUMONIA 672 0.0021
499 SINUS CONGESTION 28 0.0021
500 SKIN DISORDER 69 0.0021
501 RETINAL DETACHMENT 19 0.0021
502 BRONCHOPULMONARY ASPERGILLOSIS 16 0.0021
503 PYREXIA 714 0.0021
504 INTERVERTEBRAL DISC DEGENERATION 19 0.0021
505 BLOOD COUNT ABNORMAL 31 0.0020
506 TOOTHACHE 37 0.0020
507 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
508 ANGIOEDEMA 90 0.0020
509 DIARRHOEA HAEMORRHAGIC 19 0.0020
510 DRUG ERUPTION 36 0.0020
511 HYPOXIA 71 0.0020
512 RESPIRATORY TRACT CONGESTION 32 0.0020
513 DEVICE RELATED INFECTION 31 0.0020
514 HAEMOPTYSIS 56 0.0020
515 BLOOD GLUCOSE FLUCTUATION 22 0.0020
516 DEAFNESS 52 0.0020
517 RHINITIS 16 0.0020
518 CORONARY ARTERY DISEASE 60 0.0020
519 ANURIA 17 0.0020
520 BLOOD ALKALINE PHOSPHATASE INCREASED 49 0.0020
521 RETCHING 42 0.0020
522 DECUBITUS ULCER 16 0.0020
523 CHEST DISCOMFORT 201 0.0020
524 ACIDOSIS 15 0.0020
525 HEPATITIS 50 0.0020
526 RESPIRATORY SYNCYTIAL VIRUS INFECTION 17 0.0020
527 WEIGHT DECREASED 545 0.0020
528 EAR DISCOMFORT 20 0.0019
529 TACHYCARDIA 173 0.0019
530 MUSCLE SPASMS 356 0.0019
531 VENTRICULAR TACHYCARDIA 32 0.0019
532 CHOLECYSTITIS 23 0.0019
533 BODY TEMPERATURE DECREASED 19 0.0019
534 PELVIC FRACTURE 15 0.0019
535 DEFORMITY 18 0.0019
536 GLAUCOMA 37 0.0019
537 INTENTIONAL PRODUCT USE ISSUE 168 0.0019
538 DYSPHAGIA 182 0.0019
539 TINNITUS 88 0.0019
540 EMOTIONAL DISORDER 59 0.0019
541 MULTIPLE ALLERGIES 15 0.0019
542 DIVERTICULITIS 53 0.0019
543 ARTERIOSCLEROSIS 18 0.0019
544 DRUG DISPENSING ERROR 29 0.0019
545 GAIT DISTURBANCE 363 0.0019
546 GASTROINTESTINAL INFECTION 17 0.0019
547 TOOTH INFECTION 25 0.0019
548 BLOOD ALBUMIN DECREASED 15 0.0019
549 MEDICATION ERROR 105 0.0019
550 VASCULITIS 22 0.0019
551 DYSPNOEA 1065 0.0019
552 CONDITION AGGRAVATED 571 0.0019
553 MALNUTRITION 21 0.0019
554 BLOOD PRESSURE FLUCTUATION 45 0.0019
555 ROTATOR CUFF SYNDROME 24 0.0019
556 OROPHARYNGEAL PAIN 173 0.0019
557 PARAESTHESIA 294 0.0019
558 INJECTION SITE EXTRAVASATION 23 0.0019
559 HAEMORRHOIDS 36 0.0018
560 MYOCARDIAL ISCHAEMIA 21 0.0018
561 POST PROCEDURAL INFECTION 15 0.0018
562 CYANOSIS 29 0.0018
563 ALOPECIA 362 0.0018
564 COUGH 516 0.0018
565 DECREASED APPETITE 425 0.0018
566 PNEUMOTHORAX 29 0.0018
567 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 47 0.0018
568 ASPIRATION 20 0.0018
569 EOSINOPHILIA 32 0.0018
570 RHINORRHOEA 118 0.0018
571 PULMONARY HYPERTENSION 38 0.0018
572 ERYTHEMA MULTIFORME 17 0.0018
573 SEPTIC SHOCK 79 0.0018
574 RASH MACULAR 63 0.0018
575 APNOEA 14 0.0018
576 EMPHYSEMA 18 0.0018
577 JAUNDICE 48 0.0018
578 GOUT 32 0.0018
579 LYMPHADENOPATHY 63 0.0018
580 INFUSION SITE ERYTHEMA 15 0.0018
581 CYST 22 0.0018
582 HEART RATE IRREGULAR 40 0.0018
583 TOOTH ABSCESS 18 0.0018
584 HEPATOCELLULAR INJURY 25 0.0018
585 CIRCULATORY COLLAPSE 30 0.0018
586 ERECTILE DYSFUNCTION 45 0.0018
587 HEPATOTOXICITY 39 0.0017
588 PAIN IN EXTREMITY 512 0.0017
589 THROAT TIGHTNESS 47 0.0017
590 TARDIVE DYSKINESIA 49 0.0017
591 LOCALISED INFECTION 42 0.0017
592 TREATMENT NONCOMPLIANCE 95 0.0017
593 PARAESTHESIA ORAL 25 0.0017
594 PETECHIAE 18 0.0017
595 ACCIDENTAL OVERDOSE 63 0.0017
596 LIVER FUNCTION TEST ABNORMAL 50 0.0017
597 SEROTONIN SYNDROME 33 0.0017
598 GASTROENTERITIS VIRAL 31 0.0017
599 SINUS DISORDER 34 0.0017
600 SEPSIS 191 0.0017
601 SPLENOMEGALY 20 0.0017
602 INCONTINENCE 18 0.0017
603 SQUAMOUS CELL CARCINOMA 16 0.0017
604 THROMBOCYTOPENIA 190 0.0017
605 WEIGHT INCREASED 379 0.0017
606 TACHYPNOEA 23 0.0017
607 ILEUS 21 0.0017
608 BLOOD IRON DECREASED 20 0.0017
609 NASAL CONGESTION 99 0.0017
610 DIARRHOEA 1086 0.0017
611 TENDONITIS 26 0.0017
612 INSOMNIA 447 0.0017
613 INTESTINAL OBSTRUCTION 63 0.0017
614 HYPOKALAEMIA 77 0.0017
615 PRURITUS 641 0.0017
616 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
617 MULTIPLE ORGAN DYSFUNCTION SYNDROME 47 0.0017
618 DEVICE USE ISSUE 29 0.0017
619 VISUAL ACUITY REDUCED 55 0.0017
620 CARPAL TUNNEL SYNDROME 23 0.0016
621 BLOOD LACTATE DEHYDROGENASE INCREASED 26 0.0016
622 ADVERSE DRUG REACTION 147 0.0016
623 ARTHRALGIA 679 0.0016
624 TOOTH FRACTURE 18 0.0016
625 COELIAC DISEASE 16 0.0016
626 HYPERKALAEMIA 57 0.0016
627 SMALL INTESTINAL OBSTRUCTION 20 0.0016
628 NAUSEA 1283 0.0016
629 ABDOMINAL DISTENSION 169 0.0016
630 MALAISE 710 0.0016
631 DIZZINESS 803 0.0016
632 SKIN INFECTION 18 0.0016
633 HYPOTHYROIDISM 51 0.0016
634 RESPIRATORY DISTRESS 44 0.0016
635 FUNGAL INFECTION 53 0.0016
636 BODY HEIGHT DECREASED 17 0.0016
637 DECREASED ACTIVITY 17 0.0016
638 DYSPHONIA 92 0.0016
639 ULCER 25 0.0016
640 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
641 ADRENAL INSUFFICIENCY 19 0.0016
642 PRODUCT USE IN UNAPPROVED INDICATION 388 0.0016
643 CATARACT 93 0.0016
644 SENSORY DISTURBANCE 25 0.0016
645 PANCREATITIS ACUTE 35 0.0016
646 BLOOD UREA INCREASED 26 0.0016
647 LIMB DISCOMFORT 48 0.0015
648 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 85 0.0015
649 EYELID OEDEMA 18 0.0015
650 RESTLESS LEGS SYNDROME 28 0.0015
651 HAEMATEMESIS 39 0.0015
652 EXTRAPYRAMIDAL DISORDER 38 0.0015
653 FOOT FRACTURE 29 0.0015
654 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
655 DYSKINESIA 62 0.0015
656 LIGAMENT SPRAIN 15 0.0015
657 HEART RATE INCREASED 150 0.0015
658 PLEURAL EFFUSION 92 0.0015
659 INTERVERTEBRAL DISC PROTRUSION 33 0.0015
660 LIMB INJURY 41 0.0015
661 METABOLIC ACIDOSIS 48 0.0015
662 BACTERIAL INFECTION 28 0.0015
663 SALIVARY HYPERSECRETION 15 0.0015
664 TOXIC SKIN ERUPTION 15 0.0015
665 BLINDNESS UNILATERAL 21 0.0015
666 CARDIOMYOPATHY 22 0.0015
667 TRANSIENT ISCHAEMIC ATTACK 50 0.0015
668 DRY THROAT 15 0.0015
669 ASTHENIA 554 0.0015
670 GASTRIC ULCER 28 0.0015
671 PNEUMONITIS 40 0.0015
672 RESPIRATORY FAILURE 107 0.0015
673 RASH ERYTHEMATOUS 70 0.0015
674 BACK PAIN 338 0.0015
675 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
676 HEPATIC STEATOSIS 27 0.0014
677 POLLAKIURIA 60 0.0014
678 HYPERHIDROSIS 185 0.0014
679 SHOCK 33 0.0014
680 HAEMATOCHEZIA 79 0.0014
681 CARDIAC ARREST 118 0.0014
682 EMOTIONAL DISTRESS 173 0.0014
683 HEADACHE 893 0.0014
684 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
685 WRIST FRACTURE 17 0.0014
686 ARRHYTHMIA 67 0.0014
687 DYSURIA 52 0.0014
688 PAIN IN JAW 40 0.0014
689 BASAL CELL CARCINOMA 22 0.0014
690 LETHARGY 81 0.0014
691 ACUTE RESPIRATORY FAILURE 27 0.0014
692 RASH PRURITIC 76 0.0014
693 CHILLS 164 0.0014
694 SKIN ULCER 36 0.0014
695 SKIN LESION 38 0.0014
696 MYELODYSPLASTIC SYNDROME 20 0.0014
697 ABSCESS 22 0.0014
698 FATIGUE 1072 0.0014
699 ASPARTATE AMINOTRANSFERASE INCREASED 73 0.0014
700 BONE DISORDER 25 0.0014
701 URINARY TRACT INFECTION 234 0.0014
702 ADVERSE REACTION 18 0.0014
703 ANKLE FRACTURE 21 0.0014
704 DYSARTHRIA 51 0.0014
705 LUNG INFECTION 21 0.0014
706 DIPLOPIA 35 0.0013
707 RESTLESSNESS 49 0.0013
708 MIDDLE INSOMNIA 25 0.0013
709 INFLUENZA 149 0.0013
710 BLOOD CALCIUM DECREASED 15 0.0013
711 BRONCHOSPASM 19 0.0013
712 SKIN DISCOLOURATION 61 0.0013
713 HYPOAESTHESIA ORAL 20 0.0013
714 RENAL IMPAIRMENT 111 0.0013
715 PAIN 808 0.0013
716 PALPITATIONS 153 0.0013
717 FACE OEDEMA 22 0.0013
718 HALLUCINATION 98 0.0013
719 BLOOD POTASSIUM DECREASED 39 0.0013
720 BLOOD BILIRUBIN INCREASED 35 0.0013
721 ATRIAL FIBRILLATION 126 0.0013
722 BACK DISORDER 21 0.0013
723 ERYTHEMA 265 0.0013
724 DERMATITIS 27 0.0013
725 MYALGIA 219 0.0013
726 TOOTH EXTRACTION 16 0.0013
727 LOSS OF CONSCIOUSNESS 164 0.0013
728 PULMONARY MASS 19 0.0013
729 PRESYNCOPE 31 0.0013
730 CONSTIPATION 278 0.0013
731 EYE HAEMORRHAGE 17 0.0013
732 COVID-19 PNEUMONIA 15 0.0013
733 OSTEOMYELITIS 23 0.0013
734 TREMOR 210 0.0013
735 FEAR 34 0.0013
736 LOCAL SWELLING 22 0.0013
737 PALLOR 34 0.0012
738 DEEP VEIN THROMBOSIS 81 0.0012
739 UNRESPONSIVE TO STIMULI 32 0.0012
740 INFLUENZA LIKE ILLNESS 102 0.0012
741 HYPERGLYCAEMIA 45 0.0012
742 PRODUCT USE ISSUE 232 0.0012
743 APATHY 18 0.0012
744 MELAENA 27 0.0012
745 BRADYCARDIA 65 0.0012
746 CHOLECYSTECTOMY 14 0.0012
747 ILLNESS 126 0.0012
748 DISEASE RECURRENCE 58 0.0012
749 UNDERDOSE 89 0.0012
750 PARANOIA 21 0.0012
751 ADVERSE EVENT 112 0.0012
752 MOVEMENT DISORDER 39 0.0012
753 TOOTH DISORDER 27 0.0012
754 HERPES ZOSTER 69 0.0012
755 PNEUMONIA ASPIRATION 30 0.0012
756 HAEMATURIA 41 0.0012
757 HEART RATE DECREASED 42 0.0012
758 MENTAL STATUS CHANGES 33 0.0012
759 ABDOMINAL PAIN LOWER 30 0.0012
760 URINARY INCONTINENCE 35 0.0012
761 ATAXIA 14 0.0012
762 CHOKING 23 0.0012
763 COGNITIVE DISORDER 55 0.0012
764 EATING DISORDER 25 0.0012
765 OSTEONECROSIS OF JAW 29 0.0012
766 JOINT INJURY 25 0.0012
767 SCAR 20 0.0012
768 PERIPHERAL COLDNESS 16 0.0012
769 MUSCULOSKELETAL DISCOMFORT 20 0.0012
770 COLITIS 44 0.0012
771 SURGERY 68 0.0012
772 HAEMATOCRIT DECREASED 23 0.0012
773 LEUKOPENIA 58 0.0012
774 RED BLOOD CELL COUNT DECREASED 33 0.0012
775 THERAPY PARTIAL RESPONDER 18 0.0012
776 ANGINA PECTORIS 33 0.0012
777 EPISTAXIS 86 0.0011
778 POST PROCEDURAL COMPLICATION 22 0.0011
779 DEHYDRATION 152 0.0011
780 DRY SKIN 152 0.0011
781 HALLUCINATION, AUDITORY 18 0.0011
782 BLOOD PRESSURE INCREASED 173 0.0011
783 BURNING SENSATION 79 0.0011
784 PERICARDIAL EFFUSION 26 0.0011
785 SYNCOPE 112 0.0011
786 QUALITY OF LIFE DECREASED 15 0.0011
787 RASH PAPULAR 25 0.0011
788 SKIN EXFOLIATION 94 0.0011
789 ACTIVITIES OF DAILY LIVING IMPAIRED 22 0.0011
790 PANCYTOPENIA 62 0.0011
791 CARDIAC FAILURE CONGESTIVE 89 0.0011
792 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
793 DRUG EFFECT INCOMPLETE 40 0.0011
794 OFF LABEL USE 963 0.0011
795 HYPOTENSION 218 0.0011
796 ANOREXIA 14 0.0011
797 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
798 RASH GENERALISED 28 0.0011
799 ANAEMIA 206 0.0011
800 IMMUNODEFICIENCY 16 0.0011
801 HEAD DISCOMFORT 19 0.0011
802 BEDRIDDEN 14 0.0011
803 CHROMATURIA 24 0.0011
804 DIABETES MELLITUS 81 0.0011
805 HEMIPARESIS 18 0.0011
806 TOOTH LOSS 22 0.0011
807 FALL 353 0.0011
808 FRACTURE 20 0.0011
809 PULMONARY EMBOLISM 100 0.0011
810 PROTEINURIA 20 0.0011
811 NEUROPATHY PERIPHERAL 100 0.0011
812 GASTRIC DISORDER 36 0.0010
813 URINARY RETENTION 35 0.0010
814 PANIC ATTACK 38 0.0010
815 HALLUCINATION, VISUAL 22 0.0010
816 BLOOD CREATININE INCREASED 68 0.0010
817 BLOOD PRESSURE DECREASED 69 0.0010
818 CYSTITIS 33 0.0010
819 FEEDING DISORDER 21 0.0010
820 ORTHOSTATIC HYPOTENSION 18 0.0010
821 PHOTOSENSITIVITY REACTION 17 0.0010
822 CORONARY ARTERY OCCLUSION 14 0.0010
823 BRAIN FOG 16 0.0010
824 BALANCE DISORDER 88 0.0010
825 SPEECH DISORDER 53 0.0010
826 HEAD INJURY 32 0.0010
827 HYPOGLYCAEMIA 49 0.0010
828 THIRST 18 0.0010
829 APPLICATION SITE PAIN 22 0.0010
830 INCREASED APPETITE 19 0.0010
831 SUICIDAL IDEATION 91 0.0010
832 APHASIA 30 0.0010
833 NERVOUS SYSTEM DISORDER 31 0.0010
834 UNEVALUABLE EVENT 75 0.0010
835 BONE DENSITY DECREASED 31 0.0010
836 MENTAL DISORDER 43 0.0010
837 NEURALGIA 24 0.0010
838 CARDIOVASCULAR DISORDER 25 0.0010
839 HAEMOGLOBIN DECREASED 101 0.0010
840 PULMONARY OEDEMA 44 0.0010
841 ERUCTATION 19 0.0010
842 HYPOPHAGIA 25 0.0010
843 CARDIOGENIC SHOCK 14 0.0010
844 DELUSION 15 0.0010
845 PRODUCT PRESCRIBING ISSUE 21 0.0010
846 CONVULSION 55 0.0010
847 DIABETIC KETOACIDOSIS 23 0.0010
848 SEIZURE 110 0.0010
849 SPINAL FRACTURE 19 0.0009
850 DEPRESSED MOOD 50 0.0009
851 COMA 45 0.0009
852 FEELING JITTERY 18 0.0009
853 PRODUCT DOSE OMISSION ISSUE 276 0.0009
854 ENCEPHALOPATHY 23 0.0009
855 BONE MARROW FAILURE 19 0.0009
856 FEELING COLD 26 0.0009
857 GASTROINTESTINAL HAEMORRHAGE 78 0.0009
858 BLOOD POTASSIUM INCREASED 15 0.0009
859 PERITONITIS 19 0.0009
860 AGRANULOCYTOSIS 17 0.0009
861 METASTASES TO BONE 15 0.0009
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 164 0.0009
863 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
864 HYPOACUSIS 39 0.0009
865 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
866 HIP FRACTURE 29 0.0009
867 AGGRESSION 45 0.0009
868 AGITATION 66 0.0009
869 IRRITABILITY 54 0.0009
870 NIGHTMARE 31 0.0009
871 BLOOD GLUCOSE DECREASED 43 0.0009
872 VERTIGO 54 0.0009
873 HEPATIC FUNCTION ABNORMAL 33 0.0009
874 SOMNOLENCE 178 0.0009
875 ABNORMAL BEHAVIOUR 35 0.0009
876 ACUTE MYOCARDIAL INFARCTION 26 0.0009
877 PRODUCT PRESCRIBING ERROR 21 0.0009
878 ECZEMA 46 0.0009
879 FAECES DISCOLOURED 19 0.0009
880 DERMATITIS ATOPIC 46 0.0009
881 COVID-19 153 0.0009
882 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
883 ORAL HERPES 17 0.0009
884 THROAT IRRITATION 39 0.0009
885 THERAPY INTERRUPTED 62 0.0009
886 FLUID RETENTION 44 0.0009
887 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
888 DISTURBANCE IN ATTENTION 46 0.0009
889 DRUG INEFFECTIVE 1122 0.0009
890 ASCITES 25 0.0008
891 HAEMATOMA 22 0.0008
892 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
893 CARDIAC FAILURE 68 0.0008
894 PSYCHOTIC DISORDER 25 0.0008
895 HYPOCALCAEMIA 16 0.0008
896 RENAL DISORDER 39 0.0008
897 RESPIRATORY ARREST 23 0.0008
898 PRURITUS GENERALISED 18 0.0008
899 HOSPITALISATION 127 0.0008
900 MUSCLE TWITCHING 19 0.0008
901 KIDNEY INFECTION 16 0.0008
902 EXPOSURE VIA SKIN CONTACT 21 0.0008
903 BONE PAIN 47 0.0008
904 HYPERSOMNIA 23 0.0008
905 PLASMA CELL MYELOMA 31 0.0008
906 DIABETES MELLITUS INADEQUATE CONTROL 14 0.0008
907 PLATELET COUNT DECREASED 84 0.0008
908 INTENTIONAL PRODUCT MISUSE 68 0.0008
909 INTENTIONAL DOSE OMISSION 22 0.0008
910 MYOCARDIAL INFARCTION 134 0.0008
911 PSORIASIS 100 0.0008
912 HYPONATRAEMIA 43 0.0008
913 NEPHROLITHIASIS 35 0.0008
914 AGEUSIA 19 0.0008
915 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 154 0.0008
916 THERAPEUTIC RESPONSE DECREASED 46 0.0008
917 IMPAIRED WORK ABILITY 16 0.0007
918 FULL BLOOD COUNT DECREASED 15 0.0007
919 FEMUR FRACTURE 23 0.0007
920 ANAPHYLACTIC SHOCK 19 0.0007
921 FEBRILE NEUTROPENIA 48 0.0007
922 FEELING ABNORMAL 172 0.0007
923 THERAPEUTIC RESPONSE UNEXPECTED 32 0.0007
924 DISORIENTATION 28 0.0007
925 FLATULENCE 40 0.0007
926 MENTAL IMPAIRMENT 17 0.0007
927 CEREBROVASCULAR ACCIDENT 117 0.0007
928 MOOD SWINGS 22 0.0007
929 CRYING 25 0.0007
930 MUCOSAL INFLAMMATION 18 0.0007
931 SEDATION 18 0.0007
932 DEMENTIA 19 0.0007
933 THROMBOSIS 54 0.0007
934 NERVOUSNESS 35 0.0007
935 CARDIO-RESPIRATORY ARREST 28 0.0007
936 HAEMORRHAGE 70 0.0007
937 MOOD ALTERED 18 0.0007
938 ABNORMAL DREAMS 18 0.0007
939 TOXICITY TO VARIOUS AGENTS 108 0.0006
940 OSTEONECROSIS 21 0.0006
941 CARDIAC DISORDER 59 0.0006
942 ANGER 21 0.0006
943 DYSGEUSIA 46 0.0006
944 NEUTROPENIA 84 0.0006
945 PROCEDURAL PAIN 17 0.0006
946 WHITE BLOOD CELL COUNT DECREASED 65 0.0006
947 VAGINAL HAEMORRHAGE 26 0.0006
948 PRODUCT COMPLAINT 15 0.0006
949 NEUTROPHIL COUNT DECREASED 24 0.0006
950 SKIN BURNING SENSATION 42 0.0006
951 PRODUCT QUALITY ISSUE 78 0.0006
952 EXPIRED PRODUCT ADMINISTERED 19 0.0006
953 HOT FLUSH 43 0.0006
954 INCORRECT DRUG ADMINISTRATION DURATION 16 0.0006
955 DYSSTASIA 16 0.0005
956 FLUSHING 55 0.0005
957 DRUG EFFECT DECREASED 29 0.0005
958 NEEDLE ISSUE 15 0.0005
959 CEREBRAL HAEMORRHAGE 18 0.0005
960 LACTIC ACIDOSIS 16 0.0005
961 ACNE 37 0.0005
962 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
963 DISEASE PROGRESSION 57 0.0005
964 BLOOD GLUCOSE INCREASED 85 0.0005
965 INJECTION SITE BRUISING 35 0.0004
966 NEOPLASM PROGRESSION 15 0.0004
967 INJECTION SITE REACTION 29 0.0004
968 DRUG WITHDRAWAL SYNDROME 36 0.0004
969 OVERDOSE 87 0.0004
970 SKIN IRRITATION 18 0.0004
971 INCORRECT DOSE ADMINISTERED 89 0.0004
972 PRODUCT DOSE OMISSION 25 0.0004
973 DEVICE ISSUE 34 0.0004
974 INJECTION SITE ERYTHEMA 46 0.0004
975 SUICIDE ATTEMPT 22 0.0004
976 THERAPY CESSATION 18 0.0004
977 DEATH 291 0.0003
978 COMPLETED SUICIDE 28 0.0003
979 NO ADVERSE EVENT 60 0.0003
980 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
981 PRODUCT STORAGE ERROR 28 0.0003
982 NEOPLASM MALIGNANT 21 0.0003
983 DRUG DOSE OMISSION 51 0.0003
984 ACCIDENTAL EXPOSURE TO PRODUCT 29 0.0003
985 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
986 BREAST CANCER 25 0.0003
987 INJECTION SITE PAIN 77 0.0003
988 DRUG DEPENDENCE 37 0.0002
989 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
990 INJECTION SITE PRURITUS 15 0.0002
991 INJECTION SITE SWELLING 15 0.0002
992 DRUG ABUSE 14 0.0002